Addition Therapeutics
The role involves performing analytical testing and characterization of plasmid DNA, RNA, and lipid nanoparticle formulations, as well as developing, optimizing, and qualifying analytical methods to support process development and preclinical manufacturing of RNA therapeutics. The associate will work collaboratively with Process Development, Formulation, and CMC teams in a fast‑paced startup environment, documenting data, troubleshooting assays, and maintaining laboratory operations.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Addition Therapeutics.
4% above the average for this role